Loading...
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS
Glioblastoma is the most common primary brain tumor in adults; with a survival rate of 12 months from diagnosis. However, a small subgroup of patients, termed long-term survivors (LTS), has a survival rate longer then 12–14 months. There is thus increasing interest in the identification of molecular...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4991399/ https://ncbi.nlm.nih.gov/pubmed/26799668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6968 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|